Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
- 31 July 2001
- journal article
- research article
- Published by Elsevier
- Vol. 35 (1) , 17-23
- https://doi.org/10.1016/s0168-8278(01)00066-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Up-Regulation of Peroxisome Proliferator-Activated Receptors (PPAR- ) and PPAR- Messenger Ribonucleic Acid Expression in the Liver in Murine Obesity: Troglitazone Induces Expression of PPAR- -Responsive Adipose Tissue-Specific Genes in the Liver of Obese Diabetic MiceEndocrinology, 2000
- Body Composition and Hepatic Steatosis As Precursors for Fibrotic Liver DiseaseHepatology, 1999
- Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and SteatosisHepatology, 1999
- Peroxisome Proliferator-activated Receptor α-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and SteatosisJournal of Biological Chemistry, 1998
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Troglitazone action is independent of adipose tissue.Journal of Clinical Investigation, 1997
- Pioglitazone: In vitro Effects on Rat Hepatoma Cells and in vivo Liver Hypertrophy in KKAv MicePharmacology, 1997
- Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.Journal of Clinical Investigation, 1996
- General Survey of Diabetic Features of Yellow KK MiceEndocrinologia Japonica, 1970